USD 0.13
(2.84%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 6.57 Million USD | 35.86% |
2020 | 4.83 Million USD | 106.89% |
2019 | 2.33 Million USD | 31.16% |
2018 | 1.78 Million USD | 11124.7% |
2017 | 15.88 Thousand USD | -75.78% |
2016 | 65.6 Thousand USD | 650.14% |
2015 | 8745.00 USD | -2.52% |
2014 | 8971.00 USD | -66.1% |
2013 | 26.46 Thousand USD | -89.86% |
2012 | 261.04 Thousand USD | 22.69% |
2011 | 212.77 Thousand USD | 9.66% |
2010 | 194.02 Thousand USD | 12.88% |
2009 | 171.89 Thousand USD | 26.65% |
2008 | 135.71 Thousand USD | 156.75% |
2007 | 52.86 Thousand USD | 75.31% |
2006 | 30.15 Thousand USD | 47.03% |
2005 | 20.5 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2022 Q3 | 7.21 Million USD | 3.54% |
2022 Q2 | 6.96 Million USD | 5.38% |
2022 Q1 | 6.61 Million USD | 0.58% |
2021 FY | 6.57 Million USD | 35.86% |
2021 Q4 | 6.57 Million USD | 12.02% |
2021 Q3 | 5.86 Million USD | -1.16% |
2021 Q2 | 5.93 Million USD | 9.42% |
2021 Q1 | 5.42 Million USD | 12.14% |
2020 FY | 4.83 Million USD | 106.89% |
2020 Q1 | 3.04 Million USD | 30.36% |
2020 Q2 | 3.73 Million USD | 22.36% |
2020 Q4 | 4.83 Million USD | 24.73% |
2020 Q3 | 3.87 Million USD | 3.99% |
2019 Q3 | 13.08 Million USD | 4.11% |
2019 Q4 | 2.33 Million USD | -82.13% |
2019 Q1 | 13.99 Million USD | 602.61% |
2019 FY | 2.33 Million USD | 31.16% |
2019 Q2 | 12.57 Million USD | -10.13% |
2018 Q1 | 12.29 Thousand USD | -22.63% |
2018 FY | 1.78 Million USD | 11124.7% |
2018 Q4 | 1.99 Million USD | 34424.46% |
2018 Q3 | 5768.00 USD | -79.48% |
2018 Q2 | 28.11 Thousand USD | 128.73% |
2017 Q4 | 15.88 Thousand USD | -46.49% |
2017 Q2 | 19.98 Thousand USD | 33.18% |
2017 Q1 | 15 Thousand USD | -77.12% |
2017 FY | 15.88 Thousand USD | -75.78% |
2017 Q3 | 29.69 Thousand USD | 48.54% |
2016 FY | 65.6 Thousand USD | 650.14% |
2016 Q4 | 65.6 Thousand USD | 11.01% |
2016 Q3 | 59.09 Thousand USD | 228.62% |
2016 Q2 | 17.98 Thousand USD | 59.69% |
2016 Q1 | 11.26 Thousand USD | 28.77% |
2015 Q1 | 10.54 Thousand USD | 17.56% |
2015 Q3 | 12.68 Thousand USD | 48.18% |
2015 Q4 | 8745.00 USD | -31.05% |
2015 FY | 8745.00 USD | -2.52% |
2015 Q2 | 8560.00 USD | -18.83% |
2014 Q1 | 10.6 Thousand USD | -59.94% |
2014 Q2 | 13.84 Thousand USD | 30.6% |
2014 Q4 | 8971.00 USD | 9.23% |
2014 Q3 | 8213.00 USD | -40.67% |
2014 FY | 8971.00 USD | -66.1% |
2013 Q2 | 284.39 Thousand USD | 2.6% |
2013 Q3 | 298.93 Thousand USD | 5.11% |
2013 FY | 26.46 Thousand USD | -89.86% |
2013 Q1 | 277.18 Thousand USD | 6.18% |
2013 Q4 | 26.46 Thousand USD | -91.15% |
2012 Q1 | 217.56 Thousand USD | 2.25% |
2012 FY | 261.04 Thousand USD | 22.69% |
2012 Q4 | 261.04 Thousand USD | 6.95% |
2012 Q3 | 244.08 Thousand USD | 8.32% |
2012 Q2 | 225.32 Thousand USD | 3.57% |
2011 Q4 | 212.77 Thousand USD | -1.31% |
2011 Q2 | 206.03 Thousand USD | 3.83% |
2011 Q1 | 198.43 Thousand USD | 2.27% |
2011 Q3 | 215.6 Thousand USD | 4.64% |
2011 FY | 212.77 Thousand USD | 9.66% |
2010 Q4 | 194.02 Thousand USD | 5.47% |
2010 Q3 | 183.96 Thousand USD | 3.69% |
2010 Q2 | 177.41 Thousand USD | 2.14% |
2010 Q1 | 173.7 Thousand USD | 1.05% |
2010 FY | 194.02 Thousand USD | 12.88% |
2009 Q4 | 171.89 Thousand USD | -0.05% |
2009 Q1 | 163.89 Thousand USD | 20.76% |
2009 Q3 | 171.98 Thousand USD | 0.34% |
2009 FY | 171.89 Thousand USD | 26.65% |
2009 Q2 | 171.4 Thousand USD | 4.59% |
2008 Q1 | 54.78 Thousand USD | 3.64% |
2008 Q3 | 107.48 Thousand USD | 51.06% |
2008 FY | 135.71 Thousand USD | 156.75% |
2008 Q4 | 135.71 Thousand USD | 26.27% |
2008 Q2 | 71.15 Thousand USD | 29.89% |
2007 Q1 | 32.15 Thousand USD | 6.63% |
2007 Q2 | 39.53 Thousand USD | 22.96% |
2007 Q3 | 39.62 Thousand USD | 0.22% |
2007 Q4 | 52.86 Thousand USD | 33.41% |
2007 FY | 52.86 Thousand USD | 75.31% |
2006 FY | 30.15 Thousand USD | 47.03% |
2006 Q4 | 30.15 Thousand USD | 0.0% |
2005 FY | 20.5 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
The Amacore Group, Inc. | 24.7 Million USD | 100.0% |
Arem Pacific Corporation | 304.9 Thousand USD | 100.0% |
Assisted 4 Living, Inc. | 184.16 Thousand USD | 100.0% |
BioCorRx Inc. | 10.34 Million USD | 100.0% |
Bionik Laboratories Corp. | 5 Million USD | 100.0% |
Banyan Corp. | 4.51 Million USD | 100.0% |
Clearday, Inc. | 65.13 Million USD | 100.0% |
Dental Patient Care America, Inc. | 1.8 Million USD | 100.0% |
Quantum Medical Transport, Inc. | 1504.02 USD | 100.0% |
Empower Clinics Inc. | 9.18 Million USD | 100.0% |
First Choice Healthcare Solutions, Inc. | 31.65 Million USD | 100.0% |
Selectis Health, Inc. | 43.63 Million USD | 100.0% |
Ethema Health Corporation | 17.71 Million USD | 100.0% |
HealthLynked Corp. | 3.47 Million USD | 100.0% |
Healthcare Solutions Management Group, Inc. | 14.47 Million USD | 100.0% |
JRSIS Health Care Corporation | 2.3 Million USD | 100.0% |
Comjoyful International Company | 6.32 Million USD | 100.0% |
Medical Facilities Corporation | 235.37 Million USD | 100.0% |
MedSmart Group Inc. | 927.53 Thousand USD | 100.0% |
North America Frac Sand, Inc. | 936.85 Thousand USD | 100.0% |
Nova Leap Health Corp. | 2.69 Million USD | 100.0% |
Nexteligent Holdings, Inc. | 2.88 Million USD | 100.0% |
PAO Group, Inc. | 1.04 Million USD | 100.0% |
Primemd Inc. | 7.98 Million USD | 100.0% |
Raffles Medical Group Ltd | 367.04 Million USD | 100.0% |
Ryman Healthcare Limited | 5.17 Billion USD | 100.0% |
Stem Cell Authority, Ltd. | 80.52 Thousand USD | 100.0% |
SETO Holdings, Inc. | - USD | NaN% |
Optima Medical Innovations Corp. | 3.91 Million USD | 100.0% |
Mycotopia Therapies, Inc. | 4.24 Million USD | 100.0% |
U.S. NeuroSurgical Holdings, Inc. | 676 Thousand USD | 100.0% |
Veltex Corporation | 2.87 Million USD | 100.0% |
World Financial Holding Group | 132.5 Thousand USD | 100.0% |
Xcelerate Inc. | 2.07 Million USD | 100.0% |